|
|
(10 intermediate revisions not shown) |
Line 1: |
Line 1: |
- | <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" | + | <html xmlns="http://www.w3.org/1999/xhtml" dir="ltr" |
- | dir="ltr" lang="en-US"> | + | lang="en-US"> |
| <head> | | <head> |
- | <meta http-equiv="Content-Type" | + | <meta content="text/html; charset=UTF-8" |
- | content="text/html; charset=UTF-8" />
| + | http-equiv="Content-Type" /> |
- | <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" /> | + | <meta content="IE=EmulateIE7" http-equiv="X-UA-Compatible" /> |
| <title>FREiGEM</title> | | <title>FREiGEM</title> |
- | <script type="text/javascript" src="script.js"></script> | + | <script src="script.js" type="text/javascript"></script> |
- | <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css" | + | <link media="screen" type="text/css" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css" |
- | type="text/css" media="screen" /> | + | rel="stylesheet" /> |
- | <!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css_ie7&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]--> | + | <!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]--> |
| </head> | | </head> |
| <body> | | <body> |
Line 32: |
Line 32: |
| <div class="r"></div> | | <div class="r"></div> |
| <ul class="art-menu"> | | <ul class="art-menu"> |
- | <li><a href="https://2009.igem.org/Team:Freiburg_bioware" | + | <li><a href="https://2009.igem.org/Team:Freiburg_bioware"><span |
- | class="active"><span class="l"></span><span
| + | class="l"></span><span class="r"></span><span |
- | class="r"></span><span class="t">Home</span></a></li>
| + | class="t">Home</span></a></li> |
| <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span | | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span |
| class="l"></span><span class="r"></span><span | | class="l"></span><span class="r"></span><span |
Line 45: |
Line 45: |
| </ul> | | </ul> |
| </li> | | </li> |
- | <li><a | + | <li><a class="active" |
| href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span | | href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span |
| class="l"></span><span class="r"></span><span | | class="l"></span><span class="r"></span><span |
Line 54: |
Line 54: |
| href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a> | | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a> |
| </li> | | </li> |
- | <li><a
| + | |
- | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Subprojects">Subprojects</a></li>
| + | |
| <li><a | | <li><a |
| href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li> | | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li> |
Line 73: |
Line 72: |
| </ul> | | </ul> |
| </li> | | </li> |
- | <li><a | + | <li><a href="#"><span class="l"></span><span |
- | href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><span
| + | class="r"></span><span class="t">Notebook</span></a></li> |
- | class="l"></span><span class="r"></span><span
| + | |
- | class="t">Notebook</span></a></li>
| + | |
| <li><a | | <li><a |
| href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span | | href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span |
Line 97: |
Line 94: |
| href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span | | href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span |
| class="l"></span><span class="r"></span><span | | class="l"></span><span class="r"></span><span |
- | class="t">Modeling</span></a></li> | + | class="t">Modeling</span></a> </li> |
| </ul> | | </ul> |
| </div> | | </div> |
Line 126: |
Line 123: |
| | | |
| | | |
- | <table> | + | |
| + | <table |
| + | style="float: left; text-align: left; margin-top: 2px; margin-right: 20px; margin-bottom: 15px; background-color: rgb(205, 219, 229); width: 263px; height: 237px;" |
| + | border="1" cellpadding="2" cellspacing="0"> |
| + | <tbody bgcolor="#e2eff9"> |
| <tr> | | <tr> |
- | <td><span class="image"><img | + | <td><img style="width: 250px; height: 240px;" |
- | style="border: 0px solid ; width: 250px; height: 250px;"
| + | alt="" |
- | alt="Figure1: Human c-Fos:c-Jun:DNA complexes" | + | src="https://static.igem.org/mediawiki/2009/5/57/Freiburg09_1FOS.jpg" /></td> |
- | src="https://static.igem.org/mediawiki/2009/5/57/Freiburg09_1FOS.jpg" | + | |
- | class="thumbimage" /></span></td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td>Human c-Fos:c-Jun:DNA complexes</td> | + | <td><small>Figure1: Human c-Fos:c-Jun:DNA complexes</small></td> |
| </tr> | | </tr> |
| </tbody> | | </tbody> |
| </table> | | </table> |
| + | |
| </div> | | </div> |
| </div> | | </div> |
Line 145: |
Line 145: |
| We also thought of an alternative way of binding of the heterodimeric Fok to the DNA avoiding the necessity of labeled oligos and their binding proteins. Therefore, we used the DNA binding domain of a transcription factor as a new adapter between the Fok construts and the DNA. We focused on the binding domain of the Activator Protein-1 (AP-1), a crucial transcription factor implicated in numerous cancers. <br><br> | | We also thought of an alternative way of binding of the heterodimeric Fok to the DNA avoiding the necessity of labeled oligos and their binding proteins. Therefore, we used the DNA binding domain of a transcription factor as a new adapter between the Fok construts and the DNA. We focused on the binding domain of the Activator Protein-1 (AP-1), a crucial transcription factor implicated in numerous cancers. <br><br> |
| AP-1, which belongs to the bZIP type of transcription factors, binds DNA as a dimer like many eukaryotic transcription factor. Protein-protein interaction is mediated via a leucin zipper (ZIP), and with their basic region (b) they bind DNA. Nine homologues of the AP-1 leucine zipper region have been characterized, among them natural occurring c-Fos, c-Jun and library-designed winning peptides FosW and JunW. Each of the homologues is able to form heterodimers, some also form homodimers. <br><br> | | AP-1, which belongs to the bZIP type of transcription factors, binds DNA as a dimer like many eukaryotic transcription factor. Protein-protein interaction is mediated via a leucin zipper (ZIP), and with their basic region (b) they bind DNA. Nine homologues of the AP-1 leucine zipper region have been characterized, among them natural occurring c-Fos, c-Jun and library-designed winning peptides FosW and JunW. Each of the homologues is able to form heterodimers, some also form homodimers. <br><br> |
| + | |
| + | |
| There are two classes of core DNA sequences, the sequences TRE (TGACTCA) and CRE (TGACGTCA), which are recognized by the different AP-1 factors. <br><br> | | There are two classes of core DNA sequences, the sequences TRE (TGACTCA) and CRE (TGACGTCA), which are recognized by the different AP-1 factors. <br><br> |
| For our needs, we chose the natural bZIP sequence of Fos and Jun as well as the library-selected FosW sequence. By fusion of Fos with Splitli-Fok_a, the construct Fos-Splitli-Fok_a was obtained. Control of DNA cleavage occurs on two levels: (i) using the bZIP sequence of Jun as adapter, DNA binding can be induced, and (ii) adding Fok_i will render Fok activ leading to DNA cleavage. <br><br> | | For our needs, we chose the natural bZIP sequence of Fos and Jun as well as the library-selected FosW sequence. By fusion of Fos with Splitli-Fok_a, the construct Fos-Splitli-Fok_a was obtained. Control of DNA cleavage occurs on two levels: (i) using the bZIP sequence of Jun as adapter, DNA binding can be induced, and (ii) adding Fok_i will render Fok activ leading to DNA cleavage. <br><br> |
- | <table style="text-align: left; width: 412px; height: 303px;"
| + | For further control of DNA cleavage activity, a light-switchable peptide, FosW, can be used to interfere with Fos/Jun DNA binding. For this, two Cys residues were introdued in FosW presenting reactive sites for thiol-reactive linkers. Thus an azobenzene derivative as intramolecular cross-linker can be coupled to the cysteines. Depending on the wavelenth of light used the linker undergoes cis/trans isomerization promoting the folding or unfolding of the FosW helix (see Figure 3). <br> |
- | border="0" cellpadding="2" cellspacing="2">
| + | <p style="text-align: center"> |
- | <tbody>
| + | |
- | <tr>
| + | |
- | <td><a
| + | |
- | href="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/index.php/Image:Freiburg09_021009-HisFluASplitFoki_%2B_%C3%9Flac-his_highres%2Bbearbeitet.jpg"
| + | |
- | class="image"
| + | |
- | title="Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls"><img
| + | |
- | alt="Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls"
| + | |
- | src="https://static.igem.org/mediawiki/2009/2/26/Freiburg09_Fos_jun_bind.png"
| + | |
- | class="thumbimage" border="0" height="350"
| + | |
- | width="470" /></a></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td>Figure 2: His-Split-Fok_a and Jun dimerize and bind the DNA</td>
| + | |
- | </tr>
| + | |
- | </tbody>
| + | |
- | </table>
| + | |
- | For further control of DNA cleavage activity, a light-switchable peptide, FosW, can be used to interfere with Fos/Jun DNA binding. For this, two Cys residues were introdued in FosW presenting reactive sites for thiol-reactive linkers. Thusan azobenzene derivative as intramolecular cross-linker can be coupled to the cysteines. Depending on the wavelenth of light used the linker undergoes cis/trans isomerization promoting the folding or unfolding of the FosW helix(see Figure 3). <br> | + | |
| <table style="text-align: center; width: 412px; height: 303px;" | | <table style="text-align: center; width: 412px; height: 303px;" |
| border="0" cellpadding="2" cellspacing="2"> | | border="0" cellpadding="2" cellspacing="2"> |
Line 183: |
Line 168: |
| </tr> | | </tr> |
| </tbody> | | </tbody> |
- | </table><br><br> | + | </table></p><br><br> |
- | Using this light-switchable FosW derivative, FosW binds in its light-activated form to Jun and Fos, diplacing them from the DNA and thus disrupts Fok-mediated DNA cleavage. Switching FosW back to its inactivated form, Jun and Fos are released, can rebind to the DNA and Fok-mediated cleavage should occur again. <br><br> | + | Using this light-switchable FosW derivative, FosW binds in its light-activated form to Jun and Fos, displacing them from the DNA and thus disrupts Fok-mediated DNA cleavage. Switching FosW back to its inactivated form, Jun and Fos are released, can rebind to the DNA and Fok-mediated cleavage should occur again. <br><br> |
- | The assay with the photoswitchable FosWinner interrupting the binding of the heterodimeric complex of Fos and Jun was already done by the laboratory of Katja Arndt in Freiburg and underlines the feasibility of the method.<br><table style="text-align: left; width: 412px; height: 303px;" | + | The assay with the photoswitchable FosWinner interrupting the binding of the heterodimeric complex of Fos and Jun was already done by the laboratory of Katja Arndt in Freiburg and underlines the feasibility of the method.<br> |
- | border="0" cellpadding="2" cellspacing="2"> | + | |
- | <tbody> | + | <p><b>Methods</b><br /> |
| + | |
| + | <table |
| + | style="margin-top: 4px; margin-left: 20px; text-align: left; float: right; background-color: rgb(205, 219, 229); width: 343px; height: 317px;" |
| + | border="1" cellpadding="2" cellspacing="0"> |
| + | <tbody bgcolor="#e2eff9"> |
| <tr> | | <tr> |
- | <td><a | + | <td><img style="width: 500px;" alt="" |
- | href="http://www.molbiotech.uni-freiburg.de/iGEM/wiki2009/index.php/Image:Freiburg09_021009-HisFluASplitFoki_%2B_%C3%9Flac-his_highres%2Bbearbeitet.jpg"
| + | src="https://static.igem.org/mediawiki/2009/e/e1/Freiburg09_Fos.fosw.scheme.png" /><br /> |
- | class="image"
| + | </td> |
- | title="Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls"><img
| + | |
- | alt="Western Blot: His-Flu_a-Split_Fok_i in pEx; lanes: NEB prestained marker broad range, pool of elution fractions 2-5, empty lane, 3 positive controls"
| + | |
- | src="https://static.igem.org/mediawiki/2009/c/c7/Freiburg09_Fosw_interrupt.png" | + | |
- | class="thumbimage" border="0" height="350"
| + | |
- | width="470" /></a></td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td>Figure 4: FosW replaces Jun and interrupts binding</td> | + | <td><small>Figure 2: Above: Fos and Jun dimerize, bind the DNA and lead Fok construct to DNA, Below: activated FosW prevents DNA binding</small></td> |
| </tr> | | </tr> |
| </tbody> | | </tbody> |
| </table> | | </table> |
- | </p>
| + | |
- | <p><b>Methods</b><br />
| + | |
| We ordered the sequences for the basic leucine zipper (bZip) domains of c-Fos linked to a His-tag for the purification. The cloning of the construct His_Fos and Splitli-Foka into the pEX expression vector was done by a triple ligation. The first insert, His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a by NgoMIV and PstI, the vector was cut open with XbaI and PstI. Now the whole construct His_Fos-Splitli-Fok_a can be expressed as a soluble protein in E. coli. For further or alternative purification in addition to His-tag/Ni-NTA purification, we used a GST-FosW fusion protein from the stock of the laboratory of Katja Arndt, where GST (glutathione S-transferase) can bind to GSH (glutathion) sepharose. GST-FosW was expressed in E. coli and bound to the GSH-Sepharose column. This can serve as affinity column for the purification of His_Fos-Splitli-Fok_a. The already expressed His-FluA-Splitli-Fok_i is serving as an expressed Fok_i protein, but any other Fok_i should work as well. | | We ordered the sequences for the basic leucine zipper (bZip) domains of c-Fos linked to a His-tag for the purification. The cloning of the construct His_Fos and Splitli-Foka into the pEX expression vector was done by a triple ligation. The first insert, His_Fos was cut out by XbaI and AgeI, the second insert, Splitli-Fok_a by NgoMIV and PstI, the vector was cut open with XbaI and PstI. Now the whole construct His_Fos-Splitli-Fok_a can be expressed as a soluble protein in E. coli. For further or alternative purification in addition to His-tag/Ni-NTA purification, we used a GST-FosW fusion protein from the stock of the laboratory of Katja Arndt, where GST (glutathione S-transferase) can bind to GSH (glutathion) sepharose. GST-FosW was expressed in E. coli and bound to the GSH-Sepharose column. This can serve as affinity column for the purification of His_Fos-Splitli-Fok_a. The already expressed His-FluA-Splitli-Fok_i is serving as an expressed Fok_i protein, but any other Fok_i should work as well. |
| For the recombinant expression, RV308 served as host for His_Fos-Splitli-Fok_a and BL21de3 for His-FluA-Splitli-Fok_i. For induction of expression, we used 0.6 mM isopropyl-beta-D-thiogalactopyranoside (IPTG). His-FluA-Splitli-Fok_i was purified to homogeneity via a Ni-NTA column, whereas His_Fos-Splitli-Fok_a will be purified by an affinity chromatography using a glutathion column with bound GST-FosW. | | For the recombinant expression, RV308 served as host for His_Fos-Splitli-Fok_a and BL21de3 for His-FluA-Splitli-Fok_i. For induction of expression, we used 0.6 mM isopropyl-beta-D-thiogalactopyranoside (IPTG). His-FluA-Splitli-Fok_i was purified to homogeneity via a Ni-NTA column, whereas His_Fos-Splitli-Fok_a will be purified by an affinity chromatography using a glutathion column with bound GST-FosW. |
Line 263: |
Line 247: |
| </tbody> | | </tbody> |
| </table> | | </table> |
- | <p>TThe recombinant expression of the single parts His_Fos-Splitli-Fok_a, GST-FosW and His-FluA-Splitli-Fok_i was performed. His-FluA-Splitli-Fok_i was successfully purified via a Ni-NTA column. The western blot with an anti-His antibody shows a band of the expected size of 467 kDa in the pooled elution fraction. GST-FosW was expressed and coupled to the GSH-sepharose column for the purification of His_Fos-Splitli-Fok_a, which will be the next step followed by the in vitro cleavage assays. | + | <p>The recombinant expression of the single parts His_Fos-Splitli-Fok_a, GST-FosW and His-FluA-Splitli-Fok_i was performed. His-FluA-Splitli-Fok_i was successfully purified via a Ni-NTA column. The western blot with an anti-His antibody shows a band of the expected size of 467 kDa in the pooled elution fraction. GST-FosW was expressed and coupled to the GSH-sepharose column for the purification of His_Fos-Splitli-Fok_a, which will be the next step followed by the in vitro cleavage assays. |
| </p> | | </p> |
| <table width="400"> | | <table width="400"> |